An Oakland health-tech company has raised $140 million in a new funding round. Vumedi, which builds an AI-powered learning platform for physicians, has raised $140 million in Series B funding, with plans to pour the money into talent, research and development, product development and outreach as it expands its clinical learning tools.
The investment came from Oak HC/FT, according to FinSMEs, which reported the round. Vumedi is led by founder and CEO Roman Giverts, and the company describes its platform as a tool that connects clinicians with specialists and peers so they can learn procedures, evaluate treatments and navigate complex cases, the outlet reports.
What the Platform Actually Does
At the center of Vumedi's pitch is scale paired with AI. The platform uses artificial intelligence to turn more than 100,000 physician-led videos and nearly 5,000 podcast episodes, spanning more than 21 medical specialties, into what the company calls an on-demand clinical resource, per the same report. Rather than leaving clinicians to sift through hours of footage, the system synthesizes multiple expert perspectives and links directly to time-stamped segments within videos.
The company says its platform now serves more than 150,000 NPI-verified clinicians and generated over 56 million minutes of learning over the past 12 months. Back in a 2018 interview, Giverts described Vumedi's mission as helping physicians make the best care decisions through what he called unbiased video education in an interview with MPO-mag.com. That same article reported the platform then had roughly 250,000 physician users and 20,000 videos contributed by more than 5,000 healthcare organizations and professionals, including partnerships with 150 hospitals and conferences such as Cleveland Clinic, Mayo Clinic and Johns Hopkins.
Funding Figures Don't All Line Up
Not every account of Vumedi's fundraising history tells the same story. A snippet from 01net referenced a $104 million investment from Oak HC/FT, though it's unclear from that report whether it describes the same financing as the newly reported $140 million round or a separate transaction. Separately, CB Insights lists Vumedi's most recent funding round as a $79.98 million Series B dated May 22, 2025, and puts the company's total raised at $82.08 million across four rounds. The available reporting does not reconcile these differing figures with the $140 million sum reported this week.
Part of a Broader AI Health-Tech Wave
Vumedi's raise lands amid a broader uptick in digital-health investment. Companies in the sector raised $7.4 billion in the first half of 2026, up roughly $1 billion from the same period in 2025, according to Fierce Healthcare. The outlet counted 244 completed deals in that window, with $4.2 billion invested in the first quarter and $3.2 billion in the second.
A notable share of that capital came in the form of megadeals. Nineteen companies raised 20 financings of at least $100 million in the first half of 2026, representing 45 percent of all capital invested, Fierce Healthcare reported, citing deals that included AI radiology company Aidoc's $150 million raise. Clinical-reference platform OpenEvidence, a comparable player in physician-facing AI tools, announced its own $210 million Series B at a $3.5 billion valuation in mid-2025, co-led by Google Ventures and Kleiner Perkins with Sequoia Capital, Coatue, Conviction and Thrive also participating, according to a release distributed via PR Newswire. That company said it planned to use its funding to expand strategic content partnerships feeding its medical knowledge library, a goal that echoes Vumedi's own stated plans to grow its content, features and formats.
For now, Vumedi's leadership has framed the new capital as fuel for expansion rather than a pivot. The company's stated plans, per FinSMEs, center on investing in people and product to expand its AI-driven video and podcast library.
